Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference42 articles.
1. Human type 3 5-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride.;Yamana;Horm Mol Biol Clin Invest,2010
2. Finasteride Study Group. Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.;Lowe;Urology,2003
3. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.;Nickel;CMAJ,1996
4. PLESS Study Group. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.;Wessells;Urology,2003
5. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.;Olsen;J Am Acad Dermatol,2006
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献